About Cytarabine Liposomal
Class: | Antineoplastic agent, Antimetabolite
Use: | Treatment of lymphomatous meningitis due to non-Hodgkin lymphoma
Adult dose: | 50 mg administered intrathecally (IT) once every 14 days; may be adjusted based on clinical response and tolerability
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended
Side effects: | Nausea, vomiting, headache, fever, dizziness, and potential for neurotoxicity including seizures
Contraindications: | Hypers
Drug Class
Antineoplastic agent, Antimetabolite
Uses & Indications
Treatment of lymphomatous meningitis due to non-Hodgkin lymphoma
Storage Requirements
Store at 20-25°C (68-77°F); protect from light; do not freeze
Manufacturer & Packaging
Manufacturer: Mundipharma GmbH, GERMANY
Package Size
1 Vial
Price & Supplier
Price in UAE: AED 15972.40
Dosage Information
Adult Dose
50 mg administered intrathecally (IT) once every 14 days; may be adjusted based on clinical response and tolerability
Pediatric Dose
Safety and efficacy not established in pediatric patients; use is not recommended
Side Effects
Nausea, vomiting, headache, fever, dizziness, and potential for neurotoxicity including seizures
Contraindications & Precautions
Hypersensitivity to cytarabine or any component of the formulation; concurrent use with other intrathecal therapies is not recommended
Important Warnings
Risk of serious neurological adverse reactions; monitor for signs of neurotoxicity; caution in patients with impaired renal function or those receiving other myelosuppressive agents
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.